{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:11:04Z","timestamp":1793373064007,"version":"4.5.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.clim.2025.110570","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T07:38:36Z","timestamp":1752651516000},"page":"110570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Iron-dependent cell death: Unlocking Ferroptosis as a key to multiple myeloma therapy"],"prefix":"10.1016","volume":"280","author":[{"given":"Fatemeh","family":"Karimian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Khademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirsalar Nikkhah","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nabigol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Mikanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Bakhtiyaridovvombaygi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader Vazifeh","family":"Shiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2025.110570_bb0005","article-title":"Research Progress on Ferroptosis in Multiple Myeloma","volume":"1\u20137","author":"Li","year":"2024","journal-title":"Curr. Treat. Options in Oncol."},{"issue":"9","key":"10.1016\/j.clim.2025.110570_bb0010","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/ajh.27422","article-title":"Multiple myeloma: 2024 update on diagnosis, risk\u2010stratification, and management","volume":"99","author":"Rajkumar","year":"2024","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.clim.2025.110570_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031649","article-title":"Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment","volume":"23","author":"Das","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2025.110570_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109622","article-title":"Andrographolide induced ferroptosis in multiple myeloma cells by regulating the P38\/Nrf2\/HO-1 pathway","volume":"742","author":"Li","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43556-024-00188-w","article-title":"Multiple myeloma: signaling pathways and targeted therapy","volume":"5","author":"Lu","year":"2024","journal-title":"Mol Biomed."},{"issue":"11","key":"10.1016\/j.clim.2025.110570_bb0030","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1038\/leu.2017.138","article-title":"Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study","volume":"31","author":"Kumar","year":"2017","journal-title":"Leukemia"},{"issue":"17","key":"10.1016\/j.clim.2025.110570_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174082","article-title":"Multiple Myeloma Therapy: Emerging Trends and Challenges","volume":"14","author":"Dima","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.clim.2025.110570_bb0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/NHH.0000000000001249","article-title":"Multiple Myeloma","volume":"42","author":"Vrtis","year":"2024","journal-title":"Home Healthc Now"},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal Transduct Target Ther [Internet]."},{"issue":"5","key":"10.1016\/j.clim.2025.110570_bb0050","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12935-024-03559-z","article-title":"Ferroptosis: insight into the treatment of hepatocellular carcinoma","volume":"24","author":"Liao","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther."},{"issue":"7","key":"10.1016\/j.clim.2025.110570_bb0065","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41419-023-05930-w","article-title":"Ferroptosis as a potential target for cancer therapy","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.clim.2025.110570_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.765859","article-title":"Ferroptosis: The Silver lining of cancer therapy","author":"Tang","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0075","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","article-title":"Targeting ferroptosis opens new avenues for the development of novel therapeutics","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther."},{"issue":"6","key":"10.1016\/j.clim.2025.110570_bb0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cbin.11137","article-title":"Cell death: a review of the major forms of apoptosis, necrosis and autophagy","volume":"43","author":"D\u2019Arcy","year":"2019","journal-title":"Cell Biol Int [Internet]."},{"issue":"2","key":"10.1016\/j.clim.2025.110570_bb0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.clim.2025.110570_bb0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm.2016.149","article-title":"Necroptosis in development, inflammation and disease","volume":"18","author":"Weinlich","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.clim.2025.110570_bb0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.clim.2025.110570_bb0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41417-019-0134-6","article-title":"Alkaliptosis: a new weapon for cancer therapy","volume":"27","author":"Liu","year":"2020","journal-title":"Cancer Gene Therapy. England"},{"issue":"10","key":"10.1016\/j.clim.2025.110570_bb0105","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.7150\/ijbs.96828","article-title":"Ferroptosis: the balance between death and survival in colorectal cancer","volume":"20","author":"Fan","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.clim.2025.110570_bb0110","doi-asserted-by":"crossref","first-page":"1447148","DOI":"10.3389\/fendo.2024.1447148","article-title":"Ferroptosis and iron metabolism in diabetes: Pathogenesis, associated complications, and therapeutic implications","volume":"15","author":"Jin","year":"2024","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.clim.2025.110570_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116761","article-title":"Decoding ferroptosis: Revealing the hidden assassin behind cardiovascular diseases","volume":"176","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010095","article-title":"Iron Metabolism in Cancer","volume":"20","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12935-024-03329-x","article-title":"Iron metabolism: backfire of cancer cell stemness and therapeutic modalities","volume":"24","author":"Yu","year":"2024","journal-title":"Cancer Cell Int [Internet]."},{"issue":"April","key":"10.1016\/j.clim.2025.110570_bb0130","article-title":"Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology","volume":"10","author":"Brown","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clim.2025.110570_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.586530","article-title":"From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells","volume":"10","author":"Grignano","year":"2020","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.clim.2025.110570_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cells12081128","article-title":"Molecular Mechanisms of Ferroptosis and Updates of Ferroptosis Studies in Cancers and Leukemia","volume":"12","author":"Akiyama","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.clim.2025.110570_bb0145","doi-asserted-by":"crossref","first-page":"1435139","DOI":"10.3389\/fimmu.2024.1435139","article-title":"Targeting ferroptosis: a new therapeutic opportunity for kidney diseases","volume":"15","author":"Long","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2025.110570_bb0150","article-title":"Induction and application of ferroptosis in cancer therapy","volume":"22(1):12","author":"Nie","year":"2022","journal-title":"Cancer Cell Int [Internet]."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12915-025-02268-x","article-title":"Ferroptosis-related LncRNAs in diseases","volume":"23","author":"Zhou","year":"2025","journal-title":"BMC Biol."},{"key":"10.1016\/j.clim.2025.110570_bb0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-nutr-082117-051732","article-title":"Iron and Cancer","author":"Torti","year":"2018","journal-title":"Annu. Rev. Nutr."},{"issue":"7","key":"10.1016\/j.clim.2025.110570_bb0165","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1158\/0008-5472.CAN-20-1641","article-title":"MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-\/Glutathione Axis","volume":"81","author":"Floros","year":"2021","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.clim.2025.110570_bb0170","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3892\/ol.2021.12918","article-title":"Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma","volume":"22","author":"Yao","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.clim.2025.110570_bb0175","doi-asserted-by":"crossref","first-page":"1475934","DOI":"10.3389\/fncel.2024.1475934","article-title":"The role of ferroptosis in neurodegenerative diseases","volume":"18","author":"Fei","year":"2024","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.clim.2025.110570_bb0180","doi-asserted-by":"crossref","first-page":"1043344","DOI":"10.3389\/fphar.2022.1043344","article-title":"Ferritinophagy, a form of autophagic ferroptosis: New insights into cancer treatment","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"March","key":"10.1016\/j.clim.2025.110570_bb0185","first-page":"1","article-title":"Regulation of ferroptosis by PI3K\/Akt signaling pathway: a promising therapeutic axis in cancer","volume":"12","author":"Su","year":"2024","journal-title":"Front Cell Dev Biol."},{"key":"10.1016\/j.clim.2025.110570_bb0190","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.freeradbiomed.2018.12.011","article-title":"DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin","volume":"131","author":"Du","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"48","key":"10.1016\/j.clim.2025.110570_bb0195","doi-asserted-by":"crossref","first-page":"33425","DOI":"10.1074\/jbc.M114.564567","article-title":"Artesunate induces cell death in human cancer cells via enhancing lysosomal function and lysosomal degradation of ferritin","volume":"289","author":"Yang","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.clim.2025.110570_bb0200","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010039","article-title":"A Dual Role of Heme Oxygenase-1 in Cancer Cells","volume":"20","author":"Chiang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2025.110570_bb0210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","article-title":"Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis","volume":"11","author":"Roh","year":"2017","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clim.2025.110570_bb0220","doi-asserted-by":"crossref","first-page":"F702","DOI":"10.1152\/ajprenal.00044.2017","article-title":"Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells","volume":"314","author":"Adedoyin","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.clim.2025.110570_bb0225","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.2147\/OTT.S254995","article-title":"The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy","volume":"13","author":"Zhao","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.clim.2025.110570_bb0230","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2020.02.015","article-title":"Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs","volume":"483","author":"Su","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0235","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","article-title":"Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer","volume":"40","author":"Yang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.clim.2025.110570_bb0240","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"Elife"},{"issue":"12","key":"10.1016\/j.clim.2025.110570_bb0245","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/ja411006a","article-title":"Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models","volume":"136","author":"Skouta","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.clim.2025.110570_bb0250","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/jcmm.13008","article-title":"Ferroptosis, a new form of cell death, and its relationships with tumourous diseases","volume":"21","author":"Yu","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.clim.2025.110570_bb0255","article-title":"Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers","volume":"130","author":"Li","year":"2020","journal-title":"Biomed Pharmacother [Internet]."},{"issue":"3","key":"10.1016\/j.clim.2025.110570_bb0260","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ."},{"issue":"7860","key":"10.1016\/j.clim.2025.110570_bb0265","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0270","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13019-023-02300-7","article-title":"Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2\/GPX4 pathway","volume":"18","author":"Li","year":"2023","journal-title":"J. Cardiothorac. Surg."},{"issue":"7","key":"10.1016\/j.clim.2025.110570_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.208","article-title":"Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells","volume":"7","author":"Ma","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.clim.2025.110570_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155174","article-title":"Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach","volume":"123","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.clim.2025.110570_bb0285","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4143\/crt.2016.572","article-title":"Ferroptosis: A Novel Anti-tumor Action for Cisplatin","volume":"50","author":"Guo","year":"2018","journal-title":"Cancer Res. Treat."},{"issue":"8","key":"10.1016\/j.clim.2025.110570_bb0290","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10937404.2023.2246876","article-title":"Buthionine sulfoximine and chemoresistance in cancer treatments: a systematic review with meta-analysis of preclinical studies","volume":"26","author":"Dos Reis","year":"2023","journal-title":"J Toxicol Environ Health B Crit Rev."},{"key":"10.1016\/j.clim.2025.110570_bb0295","article-title":"Lipid metabolism in ferroptosis and ferroptosis-based cancer therapy","volume":"12","author":"Sun","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clim.2025.110570_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.675617","article-title":"Fatty acids metabolism: the bridge between ferroptosis and ionizing radiation","volume":"9","author":"Yuan","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"8","key":"10.1016\/j.clim.2025.110570_bb0305","doi-asserted-by":"crossref","first-page":"2100396","DOI":"10.1002\/adbi.202100396","article-title":"Lipid metabolism in ferroptosis","volume":"5","author":"Lin","year":"2021","journal-title":"Adv Biol."},{"key":"10.1016\/j.clim.2025.110570_bb0310","article-title":"Free radicals and their impact on health and antioxidant defenses: a review","volume":"11(1):19","author":"Chandimali","year":"2025","journal-title":"Cell Death Discov [Internet]."},{"key":"10.1016\/j.clim.2025.110570_bb0315","doi-asserted-by":"crossref","first-page":"1545339","DOI":"10.3389\/fimmu.2025.1545339","article-title":"Lipid metabolism in ferroptosis: mechanistic insights and therapeutic potential","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0320","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13046-022-02567-z","article-title":"Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis","volume":"42","author":"Li","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","article-title":"The interaction between ferroptosis and lipid metabolism in cancer","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct Target Ther."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23507","article-title":"The application of approaches in detecting ferroptosis","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.clim.2025.110570_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006203","article-title":"Unsolved mysteries: How does lipid peroxidation cause ferroptosis?","volume":"16","author":"Feng","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.clim.2025.110570_bb0340","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.2147\/DDDT.S513343","article-title":"Traditional Chinese Medicine and Ferroptosis in Intracerebral Hemorrhage: A Potential Therapeutic Approach","volume":"19","author":"Xu","year":"2025","journal-title":"Drug Des Devel Ther."},{"issue":"5","key":"10.1016\/j.clim.2025.110570_bb0345","article-title":"Oxidative Stress and Skin Diseases: The Role of Lipid Peroxidation","volume":"14","author":"Li Pomi","year":"2025","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"3","key":"10.1016\/j.clim.2025.110570_bb0350","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/01480545.2012.720989","article-title":"Evaluation of lipid damage related to pathological and physiological conditions","volume":"36","author":"Garcia","year":"2013","journal-title":"Drug Chem. Toxicol."},{"issue":"9","key":"10.1016\/j.clim.2025.110570_bb0355","article-title":"CD44 Receptor-Mediated Ferroptosis Induction by Hyaluronic Acid Carbon Quantum Dots in Triple-Negative Breast Cancer Cells Through Downregulation of SLC7A11 Pathway","volume":"18","author":"Chandrasekaran","year":"2025","journal-title":"Mater (Basel, Switzerland)"},{"key":"10.1016\/j.clim.2025.110570_bb0360","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jprot.2013.02.004","article-title":"Pathophysiological relevance of aldehydic protein modifications","volume":"92","author":"Zarkovic","year":"2013","journal-title":"J. Proteome"},{"issue":"4","key":"10.1016\/j.clim.2025.110570_bb0365","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/med.20117","article-title":"4\u2010Hydroxynonenal: A membrane lipid oxidation product of medicinal interest","volume":"28","author":"Poli","year":"2008","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.clim.2025.110570_bb0370","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.clim.2025.110570_bb0375","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-025-01517-4","article-title":"An atlas of ferroptosis-induced secretomes","author":"Yapici","year":"2025","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0380","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/dmd.112.048991","article-title":"NADPH\u2013cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology","volume":"41","author":"Riddick","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.clim.2025.110570_bb0385","doi-asserted-by":"crossref","first-page":"1462145","DOI":"10.3389\/fmed.2025.1462145","article-title":"Ferroptosis in NAFLD: insights and the therapeutic potential of exercise","volume":"12","author":"Li","year":"2025","journal-title":"Front. Med."},{"issue":"10","key":"10.1016\/j.clim.2025.110570_bb0390","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/cr200246d","article-title":"Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease","volume":"111","author":"Haeggstrom","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.clim.2025.110570_bb0395","doi-asserted-by":"crossref","first-page":"1512980","DOI":"10.3389\/fnagi.2025.1512980","article-title":"Phospholipids and peroxisomes in ferroptosis: the therapeutic target of acupuncture regulating vascular cognitive impairment and dementia","volume":"17","author":"Zhang","year":"2025","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0400","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.clim.2025.110570_bb0405","doi-asserted-by":"crossref","first-page":"1522873","DOI":"10.3389\/fcell.2025.1522873","article-title":"Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment","volume":"13","author":"Rostami Ravari","year":"2025","journal-title":"Front cell Dev Biol."},{"issue":"44","key":"10.1016\/j.clim.2025.110570_bb0410","doi-asserted-by":"crossref","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","article-title":"Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses","volume":"113","author":"Ou","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.clim.2025.110570_bb0415","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cell.2017.09.044","article-title":"PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals","volume":"171","author":"Wenzel","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.clim.2025.110570_bb0420","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","article-title":"ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway","volume":"21","author":"Chu","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"20","key":"10.1016\/j.clim.2025.110570_bb0425","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1158\/0008-5472.CAN-16-3062","article-title":"De novo lipid synthesis facilitates gemcitabine resistance through endoplasmic reticulum stress in pancreatic cancer","volume":"77","author":"Tadros","year":"2017","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.clim.2025.110570_bb0430","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ijc.31392","article-title":"The effect of FASN inhibition on the growth and metabolism of a cisplatin\u2010resistant ovarian carcinoma model","volume":"143","author":"Papaevangelou","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clim.2025.110570_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.03.026","article-title":"Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase","volume":"509","author":"Wang","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0440","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1038\/s41467-022-31963-4","article-title":"Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer","volume":"13","author":"Bartolacci","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2025.110570_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2025.100660","article-title":"Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets","volume":"51","author":"Yin","year":"2025","journal-title":"J bone Oncol."},{"issue":"12","key":"10.1016\/j.clim.2025.110570_bb0450","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Mol. Cell"},{"issue":"49","key":"10.1016\/j.clim.2025.110570_bb0455","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2025.110570_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.586578","article-title":"Oxidative Damage and Antioxidant Defense in Ferroptosis","volume":"8","author":"Kuang","year":"2020","journal-title":"Front cell Dev Biol."},{"issue":"19","key":"10.1016\/j.clim.2025.110570_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194968","article-title":"Programmed Cell-Death by Ferroptosis: Antioxidants as Mitigators","volume":"20","author":"Kajarabille","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.clim.2025.110570_bb0470","doi-asserted-by":"crossref","first-page":"368","DOI":"10.21037\/atm-21-6942","article-title":"The critical role and molecular mechanisms of ferroptosis in antioxidant systems: a narrative review","volume":"10","author":"Liu","year":"2022","journal-title":"Ann Transl Med."},{"issue":"6","key":"10.1016\/j.clim.2025.110570_bb0475","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.24272\/j.issn.2095-8137.2024.239","article-title":"Ferroptosis in ischemic stroke: Animal models and mechanisms","volume":"45","author":"Tuo","year":"2024","journal-title":"Zool. Res."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0480","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3892\/ol.2024.14437","article-title":"Ferroptosis in cancer (Review)","volume":"28","author":"Zeng","year":"2024","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.clim.2025.110570_bb0485","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.chembiol.2020.03.014","article-title":"Achieving Life through Death: Redox Biology of Lipid Peroxidation in Ferroptosis","volume":"27","author":"Bay\u0131r","year":"2020","journal-title":"Cell Chem Biol."},{"key":"10.1016\/j.clim.2025.110570_bb0490","doi-asserted-by":"crossref","first-page":"8966368","DOI":"10.1155\/2022\/8966368","article-title":"Theaflavin-3,3\u2019-Digallate Plays a ROS-Mediated Dual Role in Ferroptosis and Apoptosis via the MAPK Pathway in Human Osteosarcoma Cell Lines and Xenografts","volume":"2022","author":"He","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"9","key":"10.1016\/j.clim.2025.110570_bb0495","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.clim.2025.110570_bb0500","article-title":"Antioxidant Systems as Modulators of Ferroptosis: Focus on Transcription Factors","volume":"13","author":"Punziano","year":"2024","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.clim.2025.110570_bb0505","article-title":"Hypoxia and ferroptosis","volume":"122","author":"Liu","year":"2024","journal-title":"Cell Signal [Internet]."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0510","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41392-024-02088-5","article-title":"In defence of ferroptosis","volume":"10","author":"Alves","year":"2025","journal-title":"Signal Transduct Target Ther."},{"issue":"2","key":"10.1016\/j.clim.2025.110570_bb0515","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis [Internet]."},{"key":"10.1016\/j.clim.2025.110570_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.626971","article-title":"The Mevalonate Pathway, a Metabolic Target in Cancer Therapy","volume":"11","author":"Guerra","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.clim.2025.110570_bb0525","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1874467209666160112123205","article-title":"Mevalonate Pathway and Human Cancers","volume":"10","author":"Bathaie","year":"2017","journal-title":"Curr. Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.clim.2025.110570_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112536","article-title":"AKT activation because of PTEN loss upregulates xCT via GSK3\u03b2\/NRF2, leading to inhibition of ferroptosis in PTEN-mutant tumor cells","volume":"42","author":"Cahuzac","year":"2023","journal-title":"Cell Rep."},{"issue":"6718","key":"10.1016\/j.clim.2025.110570_bb0535","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/17135","article-title":"Molecular characterization of mitochondrial apoptosis-inducing factor","volume":"397","author":"Susin","year":"1999","journal-title":"Nature"},{"issue":"7784","key":"10.1016\/j.clim.2025.110570_bb0540","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0545","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13046-024-03235-0","article-title":"Ferroptosis and the tumor microenvironment","volume":"43","author":"Cui","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.clim.2025.110570_bb0550","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/MMBR.68.4.603-616.2004","article-title":"New insights into type II NAD(P)H:quinone oxidoreductases","volume":"68","author":"Melo","year":"2004","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"2","key":"10.1016\/j.clim.2025.110570_bb0555","first-page":"246","article-title":"Mitochondria regulate intracellular coenzyme Q transport and ferroptotic resistance via STARD7","volume":"25","author":"Deshwal","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.clim.2025.110570_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103211","article-title":"Ferroptosis in health and disease","volume":"75","author":"Berndt","year":"2024","journal-title":"Redox Biol."},{"issue":"7924","key":"10.1016\/j.clim.2025.110570_bb0565","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","article-title":"A non-canonical vitamin K cycle is a potent ferroptosis suppressor","volume":"608","author":"Mishima","year":"2022","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.clim.2025.110570_bb0570","doi-asserted-by":"crossref","first-page":"9937","DOI":"10.7150\/thno.65480","article-title":"Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications","volume":"11","author":"Luo","year":"2021","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.clim.2025.110570_bb0575","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/157340912803519598","article-title":"CoMFA and CoMSIA studies on aryl carboxylic acid amide derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors","volume":"8","author":"Vyas","year":"2012","journal-title":"Curr Comput Aided Drug Des."},{"issue":"15","key":"10.1016\/j.clim.2025.110570_bb0580","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.7150\/thno.100080","article-title":"Ferroptosis at the nexus of metabolism and metabolic diseases","volume":"14","author":"Li","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0585","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP Cyclohydrolase 1\/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent Sci [Internet]"},{"key":"10.1016\/j.clim.2025.110570_bb0590","article-title":"Regulatory pathways and drugs associated with ferroptosis in tumors","volume":"13(6):544","author":"Wang","year":"2022","journal-title":"Cell Death Dis [Internet]."},{"issue":"5","key":"10.1016\/j.clim.2025.110570_bb0595","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol [Internet]."},{"issue":"4","key":"10.1016\/j.clim.2025.110570_bb0600","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/leu.2016.346","article-title":"Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma","volume":"31","author":"Bordini","year":"2017","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.clim.2025.110570_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040970","article-title":"Iron Causes Lipid Oxidation and Inhibits Proteasome Function in Multiple Myeloma Cells: A Proof of Concept for Novel Combination Therapies","volume":"12","author":"Bordini","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.clim.2025.110570_bb0610","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1631\/jzus.B0740640","article-title":"Increased fatty acid synthase as a potential therapeutic target in multiple myeloma","volume":"9","author":"Wang","year":"2008","journal-title":"J Zhejiang Univ Sci B"},{"issue":"9","key":"10.1016\/j.clim.2025.110570_bb0615","doi-asserted-by":"crossref","first-page":"e46484","DOI":"10.1371\/journal.pone.0046484","article-title":"Inhibition of Fatty Acid Metabolism Reduces Human Myeloma Cells Proliferation","volume":"7","author":"Tirado-V\u00e9lez","year":"2012","journal-title":"PLoS One [Internet]"},{"key":"10.1016\/j.clim.2025.110570_bb0620","doi-asserted-by":"crossref","first-page":"7370157","DOI":"10.1155\/2020\/7370157","article-title":"Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma","volume":"2020","author":"Du","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.clim.2025.110570_bb0625","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1158\/0008-5472.CAN-3263-2","article-title":"Alteration in copy numbers of genes as a mechanism for acquired drug resistance","volume":"64","author":"Yasui","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2025.110570_bb0630","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.freeradbiomed.2023.04.003","article-title":"Targeting ABCB6 with nitidine chloride inhibits PI3K\/AKT signaling pathway to promote ferroptosis in multiple myeloma","volume":"203","author":"Yin","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.clim.2025.110570_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110687","article-title":"The selective activator protein-1 inhibitor T-5224 regulates the IRF4\/MYC axis and exerts cooperative antimyeloma activity with bortezomib","volume":"384","author":"Tang","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.clim.2025.110570_bb0640","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00277-024-05728-6","article-title":"Novel methyltransferase G9a inhibitor induces ferroptosis in multiple myeloma through Nrf2\/HO-1 pathway","volume":"103","author":"Zhang","year":"2024","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.clim.2025.110570_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155401","article-title":"Ethanol extract of Eclipta prostrata induces multiple myeloma ferroptosis via Keap1\/Nrf2\/HO-1 axis","volume":"128","author":"Li","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.clim.2025.110570_bb0650","doi-asserted-by":"crossref","first-page":"1025067","DOI":"10.3389\/fonc.2022.1025067","article-title":"Shikonin induces ferroptosis in multiple myeloma via GOT1-mediated ferritinophagy","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clim.2025.110570_bb0655","article-title":"Review of Shikonin and Derivatives: Isolation, Chemistry, Biosynthesis","volume":"13","author":"Yadav","year":"2022","journal-title":"Pharmacology and Toxicology. Front Pharmacol."},{"issue":"21","key":"10.1016\/j.clim.2025.110570_bb0660","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41388-024-03020-5","article-title":"Bone marrow stromal cells dictate lanosterol biosynthesis and ferroptosis of multiple myeloma","volume":"43","author":"Jiang","year":"2024","journal-title":"Oncogene [Internet]."},{"key":"10.1016\/j.clim.2025.110570_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118077","article-title":"FTY720 induces ferroptosis and autophagy via PP2A\/AMPK pathway in multiple myeloma cells","volume":"260","author":"Zhong","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0670","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1038\/s41467-024-50073-x","article-title":"Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis","volume":"15","author":"Xian","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2025.110570_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174397","article-title":"ACSL family: The regulatory mechanisms and therapeutic implications in cancer","volume":"909","author":"Quan","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.clim.2025.110570_bb0680","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/carcin\/bgad015","article-title":"ACSL4: a double-edged sword target in multiple myeloma, promotes cell proliferation and sensitizes cell to ferroptosis","volume":"44","author":"Zhang","year":"2023","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.clim.2025.110570_bb0685","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1158\/2159-8290.CD-19-1500","article-title":"The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis","volume":"11","author":"Hong","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.clim.2025.110570_bb0690","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/jcmm.14717","article-title":"Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence","volume":"24","author":"Wei","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"10.1016\/j.clim.2025.110570_bb0695","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.7150\/ijms.86409","article-title":"Artesunate induces ferroptosis by inhibiting the nuclear localization of SREBP2 in myeloma cells","volume":"20","author":"Liang","year":"2023","journal-title":"Int. J. Med. Sci."},{"issue":"9","key":"10.1016\/j.clim.2025.110570_bb0700","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/1440-1681.13805","article-title":"Ginsenoside Rh4 inhibits the malignant progression of multiple myeloma and induces ferroptosis by regulating SIRT2","volume":"50","author":"Ying","year":"2023","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"3\u20134","key":"10.1016\/j.clim.2025.110570_bb0705","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s10495-023-01909-2","article-title":"Multiple myeloma with high expression of SLC7A11\u00a0is sensitive to erastin-induced ferroptosis","volume":"29","author":"Zhang","year":"2024","journal-title":"Apoptosis"},{"issue":"21","key":"10.1016\/j.clim.2025.110570_bb0710","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25215016","article-title":"Induction of Apoptosis, Autophagy and Ferroptosis by Thymus vulgaris and Arctium lappa Extract in Leukemia and Multiple Myeloma Cell Lines","volume":"25","author":"Adham","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.clim.2025.110570_bb0715","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41375-020-0962-2","article-title":"The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma","volume":"35","author":"Longo","year":"2021","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.clim.2025.110570_bb0720","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108852","article-title":"Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome","volume":"24","author":"Plano","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.clim.2025.110570_bb0725","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1007\/s00277-024-05762-4","article-title":"Bortezomib elevates intracellular free Fe(2+) by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells","volume":"103","author":"Zhang","year":"2024","journal-title":"Ann. Hematol."},{"issue":"9","key":"10.1016\/j.clim.2025.110570_bb0730","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092287","article-title":"Omega-3 Fatty Acids DHA and EPA Reduce Bortezomib Resistance in Multiple Myeloma Cells by Promoting Glutathione Degradation","volume":"10","author":"Chen","year":"2021","journal-title":"Cells"},{"issue":"23","key":"10.1016\/j.clim.2025.110570_bb0735","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312731","article-title":"Phosphocatalytic Kinome Activity Profiling of Apoptotic and Ferroptotic Agents in Multiple Myeloma Cells","volume":"22","author":"Logie","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.clim.2025.110570_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e34397","article-title":"AP-1 inhibitor induces ferroptosis via the PI3K\/AKT pathway in multiple myeloma cells","volume":"10","author":"Tang","year":"2024","journal-title":"Heliyon"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625001457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625001457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T18:41:25Z","timestamp":1759862485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661625001457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":148,"alternative-id":["S1521661625001457"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2025.110570","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron-dependent cell death: Unlocking Ferroptosis as a key to multiple myeloma therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2025.110570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110570"}}